Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

160.31
Delayed Data
As of 3:59pm ET
 -3.65 / -2.23%
Today’s Change
95.14
Today|||52-Week Range
164.60
+42.27%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close163.96
Today’s open164.20
Day’s range158.71 - 164.52
Volume280,781
Average volume (3 months)309,247
Market cap$7.2B
Dividend yield--
Data as of 3:59pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+84.81%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)+35.13%
P/E ratio94.3
Price/Sales12.56
Price/Book15.84

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc-0.84-1.20%
WSTWest Pharmaceutical ...+0.05+0.05%
MASIMasimo Corp-0.25-0.29%
IARTIntegra LifeSciences...+0.03+0.06%
Data as of 4:02pm ET, 09/25/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts